Surcel, M.; Nemeti, G.; Goidescu, I.G.; Micu, R.; Zlatescu-Marton, C.; Cordos, A.A.; Caracostea, G.; Rotar, I.C.; Muresan, D.; Boitor-Borza, D.
Growth Hormone Therapy in Recurrent Implantation Failure: Stratification by FSH Receptor Polymorphism (Asn680Ser) Reveals Genotype-Specific Benefits. Int. J. Mol. Sci. 2025, 26, 7367.
https://doi.org/10.3390/ijms26157367
AMA Style
Surcel M, Nemeti G, Goidescu IG, Micu R, Zlatescu-Marton C, Cordos AA, Caracostea G, Rotar IC, Muresan D, Boitor-Borza D.
Growth Hormone Therapy in Recurrent Implantation Failure: Stratification by FSH Receptor Polymorphism (Asn680Ser) Reveals Genotype-Specific Benefits. International Journal of Molecular Sciences. 2025; 26(15):7367.
https://doi.org/10.3390/ijms26157367
Chicago/Turabian Style
Surcel, Mihai, Georgiana Nemeti, Iulian Gabriel Goidescu, Romeo Micu, Cristina Zlatescu-Marton, Ariana Anamaria Cordos, Gabriela Caracostea, Ioana Cristina Rotar, Daniel Muresan, and Dan Boitor-Borza.
2025. "Growth Hormone Therapy in Recurrent Implantation Failure: Stratification by FSH Receptor Polymorphism (Asn680Ser) Reveals Genotype-Specific Benefits" International Journal of Molecular Sciences 26, no. 15: 7367.
https://doi.org/10.3390/ijms26157367
APA Style
Surcel, M., Nemeti, G., Goidescu, I. G., Micu, R., Zlatescu-Marton, C., Cordos, A. A., Caracostea, G., Rotar, I. C., Muresan, D., & Boitor-Borza, D.
(2025). Growth Hormone Therapy in Recurrent Implantation Failure: Stratification by FSH Receptor Polymorphism (Asn680Ser) Reveals Genotype-Specific Benefits. International Journal of Molecular Sciences, 26(15), 7367.
https://doi.org/10.3390/ijms26157367
